TENOFOVIR ALAFENAMIDE FUMARATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tenofovir Alafenamide Fumarate, and when can generic versions of Tenofovir Alafenamide Fumarate launch?
Tenofovir Alafenamide Fumarate is a drug marketed by Apotex and is included in one NDA.
The generic ingredient in TENOFOVIR ALAFENAMIDE FUMARATE is tenofovir alafenamide fumarate. There are forty-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the tenofovir alafenamide fumarate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TENOFOVIR ALAFENAMIDE FUMARATE?
- What are the global sales for TENOFOVIR ALAFENAMIDE FUMARATE?
- What is Average Wholesale Price for TENOFOVIR ALAFENAMIDE FUMARATE?
Summary for TENOFOVIR ALAFENAMIDE FUMARATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 113 |
| Clinical Trials: | 82 |
| Patent Applications: | 228 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for TENOFOVIR ALAFENAMIDE FUMARATE |
| DailyMed Link: | TENOFOVIR ALAFENAMIDE FUMARATE at DailyMed |
Recent Clinical Trials for TENOFOVIR ALAFENAMIDE FUMARATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Chiang Mai University, Thailand | Phase 3 |
| ANRS, Emerging Infectious Diseases | Phase 3 |
| Assistance Publique - Hôpitaux de Paris, FRANCE | Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for TENOFOVIR ALAFENAMIDE FUMARATE
Paragraph IV (Patent) Challenges for TENOFOVIR ALAFENAMIDE FUMARATE
| Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
|---|---|---|---|---|---|---|
| VEMLIDY | Tablets | tenofovir alafenamide fumarate | 25 mg | 208464 | 6 | 2019-11-05 |
US Patents and Regulatory Information for TENOFOVIR ALAFENAMIDE FUMARATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apotex | TENOFOVIR ALAFENAMIDE FUMARATE | tenofovir alafenamide fumarate | TABLET;ORAL | 213867-001 | Mar 21, 2024 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
